About Growth/differentiation factor 8
Growth/differentiation factor 8 (MSTN) is a protein
from Homo sapiens identified by UniProt accession
O14793, 375 residues long.
MolForge cross-references it against 0 known binders and
615 disease associations.
Target properties
| Protein name | Growth/differentiation factor 8 |
| UniProt accession | O14793 |
| Gene | MSTN |
| Organism | Homo sapiens |
| Length | 375 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (615)
Diseases linked to this target (Open Targets).
- myostatin-related muscle hypertrophy · score 0.51
- spinal muscular atrophy, type III · score 0.32
- creatinine measurement · score 0.29
- Atrophy · score 0.26
- proximal spinal muscular atrophy · score 0.26
- lean body mass · score 0.16
- Duchenne muscular dystrophy · score 0.12
- cancer · score 0.11
- sarcopenia · score 0.11
- Rheumatoid arthritis · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O14793-F1 | alphafold | PREDICTED | 78.78 | — |
Amino-acid sequence (375 residues)
MQKLQLCVYI YLFMLIVAGP VDLNENSEQK ENVEKEGLCN ACTWRQNTKS SRIEAIKIQI LSKLRLETAP NISKDVIRQL LPKAPPLREL IDQYDVQRDD SSDGSLEDDD YHATTETIIT MPTESDFLMQ VDGKPKCCFF KFSSKIQYNK VVKAQLWIYL RPVETPTTVF VQILRLIKPM KDGTRYTGIR SLKLDMNPGT GIWQSIDVKT VLQNWLKQPE SNLGIEIKAL DENGHDLAVT FPGPGEDGLN PFLEVKVTDT PKRSRRDFGL DCDEHSTESR CCRYPLTVDF EAFGWDWIIA PKRYKANYCS GECEFVFLQK YPHTHLVHQA NPRGSAGPCC TPTKMSPINM LYFNGKEQII YGKIPAMVVD RCGCS
Explore Growth/differentiation factor 8 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets